FDA OKs Blood-Based Test to Help Detect High-Grade Prostate Tumors

By News Health
2 hours Ago

(MedPage Today) — The FDA approved Cleveland Diagnostics’ blood-based test to help diagnose high-grade prostate tumors and aid in biopsy decisions, the company announced.
Dubbed IsoPSA, the in vitro diagnostic kit is indicated for men ages 50…

Source link : https://www.medpagetoday.com/urology/prostatecancer/118778

Author :

Publish date : 2025-12-01 22:21:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

No-to-Low Risk for Gestational Diabetes With Oral Corticosteroids

AI Model Outperformed Density Assessment in Stratifying Breast Cancer Risk

Corticosteroids May Boost Short-Term Survival in Pneumonia, ARDS

Advanced Practice Providers Are Trapped in Liminal Space

U.K. and U.S. Agree on Zero-Tariff Deal on Pharmaceuticals

Newer Inotrope Fails to Wean Cardiogenic Shock Patients Off of ECMO